2-(5-(tert-Butoxycarbonyl)-2-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-7-yl)acetic acid

Catalog No.: 
ACTDGP812
CAS No.: 
1391732-48-1
Molecular Formula: 
C14H21N3O4
Molecular Weight: 
295.34
2-(5-(tert-Butoxycarbonyl)-2-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-7-yl)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$931.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(5-(tert-Butoxycarbonyl)-2-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-7-yl)acetic acid
IUPAC Name2-(5-(tert-butoxycarbonyl)-2-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-7-yl)acetic acid
MDL No.MFCD23378350
Molecular FormulaC14H21N3O4
Molecular Weight295.34
SMILESO=C(O)CC1C2=NN(C)C=C2CN(C(OC(C)(C)C)=O)C1
InChI KeyUJUHGOZSWVTMAS-UHFFFAOYSA-N
Synonym2-(5-(Tert-Butoxycarbonyl)-2-Methyl-4,5,6,7-Tetrahydro-2H-Pyrazolo[4,3-C]Pyridin-7-Yl)Acetic Acid(WX141196);2-(5-(Tert-Butoxycarbonyl)-2-Methyl-4,5,6,7-Tetrahydro-2H-Pyrazolo[4,3-C]Pyridin-7-Yl)Acetic Acid;2H-Pyrazolo[4,3-c]pyridine-7-acetic acid, 5-[(1,1-dimethylethoxy)carbonyl]-4,5,6,7-tetrahydro-2-methyl-
CAS No.1391732-48-1

Synthetic Route by SureRoute

1. ACTDGP812 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTDGP812 route product structure diagram
    ACTDGP8121391732-48-1
Inquiry

2. ACTDGP812 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTDGP812 route product structure diagram
    ACTDGP8121391732-48-1
Inquiry

3. ACTDGP812 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTDGP812 route product structure diagram
    ACTDGP8121391732-48-1
Inquiry

Comments (0)